Table 3 Summary of previous screening studies of the G2019S mutation in the Tunisian population
From: Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort
Reference | Type of study | Frequency in patients (%) | Frequency in controls (%) |
|---|---|---|---|
Ishihara et al. 2007 [13] | Familial | 38/91 (42%) | ND a |
Hulihan et al. 2008 [15] | Unrelated patients | 72/238 (30%) | 7/371(2%) |
Trinh et al. 2014 [16] | Unrelated patients Related patients | 220/570 (38%) 126/288 (45%) | 12/580 (3%) |
The present study | Unrelated patients | 84/250 (33.6%) | 3/218 (1.3%) |